EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ag85A-PEGylated Propolis Nanoparticles Exhibit Intracellular Antimycobacterial and Host-Protective Activities Against Mycobacterium tuberculosis

Sanonthinee Sookkree, Sirikwan Sangboonruang iD, Ponrut Phunpae, Siriwan Thaisakun iD, Narumon Phaonakrop, Sittiruk Roytrakul iD, Khajornsak Tragoolpua iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27167223 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Sanonthinee Sookkree und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Microbiology, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200,…. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Polyethylene Glycols, Propolis, Nanoparticles. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Council of Thailand, Chiang Mai University, Royal Golden Jubilee Ph.D. Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tuberculosis (TB), caused by the intracellular pathogen Mycobacterium tuberculosis (Mtb), remains a major global health challenge. The prolonged duration of treatment and the emergence of multidrug-resistant strains have highlighted the need for alternative therapeutic strategies. This study investigated the therapeutic potential of Ag85A aptamer-conjugated PEGylated niosomes encapsulating ethanolic extract of propolis (Ag85A-PEGNio/EEP) using Mtb-infected macrophage model. Ag85A-PEGNio/EEP exhibited efficient cellular uptake, with more than 99.8% internalization by macrophages, and trafficked host phagolysosome, facilitating targeted delivery of EEP to intracellular Mtb. Ag85A-PEGNio/EEP treatment showed an anti-mycobacterium efficacy by reducing intracellular Mtb viability by approximately 51.2% compared with untreated controls. Moreover, Ag85A-PEGNio/EEP modulated macrophage immune responses by significantly increasing the expression of the pro-inflammatory cytokines IL-12 (8.4-fold) and IL-6 (3.8-fold), while markedly decreasing the expression of the anti-inflammatory cytokine IL-10 (6.4-fold). Protein–protein interaction (PPI) network analysis further revealed the association of proteins with immune regulation and antioxidant responses in treated cells. These findings suggest that Ag85A-PEGNio/EEP functions as a dual-action therapeutic platform by enhancing intracellular anti-mycobacterial activity while balancing host immune responses. This targeted nano-delivery system represents a promising candidate for host-directed TB therapy and further investigations are needed to validate these outcomes and explore their potential applications against TB treatment challenges.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisPolyethylene GlycolsPropolisNanoparticlesAntigens, BacterialAntitubercular AgentsTuberculosisMacrophagesAnimalsBacterial ProteinsHumansCytokinesMiceHost-Directed TherapyAcyltransferases

Stichwörter der Autor:innen

Mycobacterium tuberculosisantimycobacterial activityethanolic extract of propolishost protective immune responsenanodelivery systemproteomics analysis

Substanzen

Polyethylene GlycolsPropolisAntigens, Bacterialantigen 85A, Mycobacterium tuberculosisBacterial ProteinsAntitubercular AgentsCytokinesAcyltransferases

Autor:innen und Institutionen

  • Division of Clinical Microbiology, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand.
  • Infectious Diseases Research Unit (IDRU), Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand.
  • National Center for Genetic Engineering and Biotechnology, National Science and Technology for Development Agency, Pathum Thani 12120, Thailand.

ORCID-Profile: Sirikwan Sangboonruang, Siriwan Thaisakun, Sittiruk Roytrakul, Khajornsak Tragoolpua

Förderung

  • National Research Council of Thailand
  • Chiang Mai University
  • Royal Golden Jubilee Ph.D. Program

Zitieren

APA

Sookkree, S., Sangboonruang, S., Phunpae, P., Thaisakun, S., Phaonakrop, N., Roytrakul, S., & Tragoolpua, K. (2026). Ag85A-PEGylated Propolis Nanoparticles Exhibit Intracellular Antimycobacterial and Host-Protective Activities Against Mycobacterium tuberculosis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27167223

Vancouver

Sookkree S, Sangboonruang S, Phunpae P, Thaisakun S, Phaonakrop N, Roytrakul S, et al. Ag85A-PEGylated Propolis Nanoparticles Exhibit Intracellular Antimycobacterial and Host-Protective Activities Against Mycobacterium tuberculosis. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27167223

BibTeX
@article{Sookkree2026,
  author = {Sookkree, Sanonthinee and Sangboonruang, Sirikwan and Phunpae, Ponrut and Thaisakun, Siriwan and Phaonakrop, Narumon and Roytrakul, Sittiruk and Tragoolpua, Khajornsak},
  title = {Ag85A-PEGylated Propolis Nanoparticles Exhibit Intracellular Antimycobacterial and Host-Protective Activities Against Mycobacterium tuberculosis},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27167223}
}
Kostenlos starten →